Tuning band alignment at a semiconductor-crystalline oxide heterojunction via electrostatic modulation of the interfacial dipole

Autor: Chrysler, M., Gabel, J., Lee, T. -L., Penn, A. N., Matthews, B. E., Kepaptsoglou, D. M., Ramasse, Q. M., Paudel, J. R., Sah, R. K., Grassi, J. D., Zhu, Z., Gray, A. X., LeBeau, J. M., Spurgeon, S. R., Chambers, S. A., Sushko, P. V., Ngai, J. H.

Publikováno v: Phys. Rev. Materials 5, 104603 (2021)

We demonstrate that the interfacial dipole associated with bonding across the SrTiO3/Si heterojunction can be tuned through space charge, thereby enabling the band alignment to be altered via doping. Oxygen impurities in Si act as donors that create

Externí odkaz: http://arxiv.org/abs/2105.13443

Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study.

Autor: Samples L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Voutsinas J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Fakhri B; Division of Hematology and Oncology, University of California, San Francisco, CA., Khajavian S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Spurgeon S; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR., Stephens D; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT., Skarbnik A; Novant Health, Charlotte, NC., Mato A; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Broome C; Division of Hematology and Oncology, Georgetown University, Washington, DC., Gopal A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Smith S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Lynch R; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Rainey M; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH., Kim MS; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR., Barrett-Campbell O; Hematology/Oncology Section, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Hemond E; Hematology/Oncology Section, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Tsang M; Division of Hematology and Oncology, University of California, San Francisco, CA., Ermann D; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT., Malakhov N; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY., Rao D; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Shakib-Azar M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Morrigan B; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Chauhan A; Division of Hematology and Oncology, Georgia Cancer Center, Augusta University, Augusta, GA., Plate T; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Gooley T; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Ryan K; AstraZeneca, Gaithersburg, MD., Lansigan F; Hematology/Oncology Section, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Hill B; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH., Pongas G; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Parikh SA; Department of Hematology, Mayo Clinic, Rochester, MN., Roeker L; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Allan JN; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY., Cheng R; Division of Cardiology, University of Washington, Seattle, WA., Ujjani C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.

Publikováno v: Blood advances [Blood Adv] 2024 May 14; Vol. 8 (9), pp. 2085-2093.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.

Autor: David KA; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Sundaram S; Roswell Park Cancer Institute, Buffalo, New York, USA., Kim SH; Rush University Medical Center, Chicago, Illinois, USA., Vaca R; Penn State Cancer Institute, Hershey, Pennsylvania, USA., Lin Y; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Singer S; John Theurer Cancer Center, Hackensack, New Jersey, USA., Malecek MK; Washington University in St. Louis, St. Louis, Missouri, USA., Carter J; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Zayac A; Brown University, Providence, Rhode Island, USA., Kim MS; Oregon Health & Science University, Portland, Oregon, USA., Reddy N; Vanderbilt University, Nashville, Tennessee, USA., Ney D; University of Colorado, Aurora, Colorado, USA., Habib A; University of Minnesota, Minneapolis, Minnesota, USA., Strouse C; University of Iowa, Iowa City, Iowa, USA., Graber J; University of Washington, Seattle, Washington, USA., Bachanova V; University of Minnesota, Minneapolis, Minnesota, USA., Salman S; Loyola University Medical Center, Maywood, Illinois, USA., Vendiola JA; Loyola University Medical Center, Maywood, Illinois, USA., Hossain N; Loyola University Medical Center, Maywood, Illinois, USA., Tsang M; University of California, San Francisco, California, USA., Major A; University of Chicago, Chicago, Illinois, USA., Bond DA; Division of Hematology, Ohio State University, Columbus, Ohio, USA., Agrawal P; Weill Cornell Medical College, New York City, New York, USA., Mier-Hicks A; Roswell Park Cancer Institute, Buffalo, New York, USA., Torka P; Roswell Park Cancer Institute, Buffalo, New York, USA., Rajakumar P; Rush University Medical Center, Chicago, Illinois, USA., Venugopal P; Rush University Medical Center, Chicago, Illinois, USA., Berg S; Loyola University Medical Center, Maywood, Illinois, USA., Glantz M; Penn State Cancer Institute, Hershey, Pennsylvania, USA., Goldlust SA; John Theurer Cancer Center, Hackensack, New Jersey, USA., Folstad M; University of Wisconsin, Madison, Wisconsin, USA., Kumar P; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Ollila TA; Brown University, Providence, Rhode Island, USA., Cai J; Oregon Health & Science University, Portland, Oregon, USA., Spurgeon S; Oregon Health & Science University, Portland, Oregon, USA., Sieg A; University of Iowa, Iowa City, Iowa, USA., Cleveland J; University of California, San Francisco, California, USA., Chang J; University of Wisconsin, Madison, Wisconsin, USA., Epperla N; Division of Hematology, Ohio State University, Columbus, Ohio, USA., Karmali R; Northwestern University, Chicago, Illinois, USA., Naik S; Penn State Cancer Institute, Hershey, Pennsylvania, USA., Martin P; Weill Cornell Medical College, New York City, New York, USA., Smith SM; University of Chicago, Chicago, Illinois, USA., Rubenstein J; University of California, San Francisco, California, USA., Kahl B; Washington University in St. Louis, St. Louis, Missouri, USA., Evens AM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.

Publikováno v: American journal of hematology [Am J Hematol] 2023 Jun; Vol. 98 (6), pp. 900-912. Date of Electronic Publication: 2023 Apr 05.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.